首页> 美国卫生研究院文献>BMC Endocrine Disorders >Takotsubo cardiomyopathy and transient thyrotoxicosis during combination therapy with interferon-alpha and ribavirin for chronic hepatitis C

【2h】

Takotsubo cardiomyopathy and transient thyrotoxicosis during combination therapy with interferon-alpha and ribavirin for chronic hepatitis C

机译：Takotsubo心肌病和干扰素-α和利巴韦林联合治疗慢性丙型肝炎期间的短暂甲状腺毒症

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundThyroid dysfunction is a common complication of chronic hepatitis C (CHC) and its therapy>. Takotsubo cardiomyopathy (TCM) is a multifactorial, stress related cardiomyopathy, rarely reported in association with thyrotoxicosis. Simultaneous occurrence of TCM and thyrotoxicosis due to hepatitis C and its treatment has never been reported.

机译：背景甲状腺功能障碍是慢性丙型肝炎（CHC）及其治疗的常见并发症。>。 Takotsubo心肌病（TCM）是一种多因素，与压力有关的心肌病，很少报道与甲状腺毒症有关。从未报道过由丙型肝炎引起的中医药和甲状腺毒症的同时发生及其治疗。

著录项

期刊名称 BMC Endocrine Disorders
作者
Carmen Sorina Martin; Luminita Nicoleta Ionescu; Carmen Gabriela Barbu; Anca Elena Sirbu; Ioana Maria Lambrescu; Ioana Smarandita Lacau; Doina Ruxandra Dimulescu; Simona Vasilica Fica;
展开▼
作者单位

展开▼
年(卷),期 2014(14),-1
年度 2014
页码 10
总页数 7
原文格式 PDF
正文语种
中图分类基础医学;
关键词
Takotsubo cardiomyopathy Thyrotoxicosis Chronic hepatitis C Interferon-alpha Ribavirin;

机译：Takotsubo心肌病;甲状腺毒症;慢性丙型肝炎;干扰素-α;利巴韦林;

相似文献

外文文献
中文文献
专利

1. Takotsubo cardiomyopathy and transient thyrotoxicosis during combination therapy with interferon-alpha and ribavirin for chronic hepatitis C [J] . Carmen S Martin, Luminita N Ionescu, Carmen G Barbu, BMC Endocrine Disorders . 2014,第1期

机译：Takotsubo心肌病和干扰素-α和利巴韦林联合治疗慢性丙型肝炎期间的短暂甲状腺毒症
2. Hepatitis C virus-specific CD8+ T cell frequencies are associated with the responses of pegylated interferon-alpha and ribavirin combination therapy in patients with chronic hepatitis C virus infection. [J] . Tatsumi T, Takehara T, Miyagi T, Hepatology research: the official journal of the Japan Society of Hepatology . 2011,第1期

机译：慢性丙型肝炎病毒感染患者中，丙型肝炎病毒特异的CD8 + T细胞频率与聚乙二醇化干扰素-α和利巴韦林联合治疗的反应有关。
3. High-dose interferon-alpha 2b plus ribavirin combination therapy for GB virus-C/hepatitis G virus infection--a study in patients with chronic hepatitis C. [J] . Cheng PN, Jen CM, Young KC, Hepato-gastroenterology. . 2003,第50期

机译：大剂量干扰素-α2b联合利巴韦林联合治疗GB病毒C / G肝炎病毒-慢性丙型肝炎患者的一项研究。
4. Studies of Therapy with Thymosin α 1 in Combination with Pegylated Interferon α2a and Ribavirin in Nonresponder Patients with Chronic Hepatitis C [C] . ROBERTO CAMERINI, ALESSIA CIANCIO, ALFONSO DE ROSA, International Symposiumn on Thymosins in Health and Disease; 20070321-24; Washington,DC(US) . 2007

机译：胸腺素α1联合聚乙二醇化干扰素α2a和利巴韦林治疗慢性丙型肝炎无反应者的研究
5. Ribavirin systemic and intracellular exposure and its role on viral response and anemia in chronic hepatitis c genotype 1 infection [D] . Wu, Liviawati Sutjandra. 2015

机译：利巴韦林全身和细胞内暴露及其在慢性丙型肝炎基因型1感染中对病毒反应和贫血的作用
6. Pharmacokinetics of ribavirin in combined interferon-alpha 2b and ribavirin therapy for chronic hepatitis C virus infection [O] . Akihito Tsubota, Yuichi Hirose, Namiki Izumi, 2003

机译：利巴韦林在干扰素-α2b和利巴韦林联合治疗慢性丙型肝炎病毒中的药代动力学
7. Takotsubo cardiomyopathy and transient thyrotoxicosis during combination therapy with interferon-alpha and ribavirin for chronic hepatitis C [O] . 2014

机译：Takotsubo心肌病和干扰素-α和利巴韦林联合治疗慢性丙型肝炎期间的短暂甲状腺毒症

Takotsubo cardiomyopathy and transient thyrotoxicosis during combination therapy with interferon-alpha and ribavirin for chronic hepatitis C

摘要

著录项

相似文献

相关主题

期刊订阅